Lv1
80 积分 2025-07-29 加入
Preliminary activity and safety results of KRAS G12C inhibitor glecirasib (JAB-21822) in patients with pancreatic cancer and other solid tumors
9天前
已关闭
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
9天前
已完结
A HER3-targeting antibody–drug conjugate for leptomeningeal metastasis
2个月前
已完结
Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors
3个月前
已完结
Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial
4个月前
已完结
Therapeutic options in thymomas and thymic carcinomas
4个月前
已完结
Thymoma and thymic carcinomas
4个月前
已关闭
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
4个月前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2025 edition)]
7个月前
已完结
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)
8个月前
已完结
皖公网安备34019202002308
